Received: from nahou-msmbx03v.corp.enron.com ([192.168.110.41]) by NAHOU-MSMBX05V.corp.enron.com with Microsoft SMTPSVC(5.0.2195.1600);
	 Wed, 11 Jul 2001 10:30:16 -0500
X-MimeOLE: Produced By Microsoft Exchange V6.0.4418.65
content-class: urn:content-classes:message
MIME-Version: 1.0
Content-Type: text/plain;
Content-Transfer-Encoding: binary
Subject: SALIX Pharmaceuticals research reports (SLXP)
Date: Wed, 11 Jul 2001 10:30:15 -0500
Message-ID: <11F12D1F27A2714A8007E84656D5BC0C6E80E8@NAHOU-MSMBX03V.corp.enron.com>
X-MS-Has-Attach: yes
X-MS-TNEF-Correlator: <11F12D1F27A2714A8007E84656D5BC0C6E80E8@NAHOU-MSMBX03V.corp.enron.com>
Thread-Topic: SALIX Pharmaceuticals research reports (SLXP)
Thread-Index: AcEKHmI1jW7Vs0srT8+Oh49t2/w/hw==
From: "Gualy, Jaime" <Jaime.Gualy@ENRON.com>
To: "Stepenovitch, Joe" <Joe.Stepenovitch@ENRON.com>
Return-Path: Jaime.Gualy@ENRON.com

Joe,

I believe this is the company.  I have compiled several reports on it and are sending these your way.

Jaime

     

